Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin (Q42977629)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 April 2008
edit
Language Label Description Also known as
English
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin
scientific article published on 7 April 2008

    Statements

    Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin (English)
    V G Bain
    E M Yoshida
    M DeschĂȘnes
    M Sherman
    R Bailey
    H Witt-Sullivan
    M Krajden
    Canadian PEGASYS Study Group
    7 April 2008
    43-50

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit